Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    19117896 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Polio;   Haemophilus Influenzae Type b
Interventions: Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine);   Biological: Pentacel: DTaP-IPV/Hib
To Top

† Indicates status has not been verified in more than two years